Vericel Enters Into $10 Million Credit Facility and $5 Million Term Loan Agreement With Silicon Valley Bank

Biotech Investing

Vericel Corporation (NASDAQ:VCEL) announced that it has entered into a term loan and revolving line of credit agreement with Silicon Valley Bank, providing access to up to $15 million of new capital to the company to be used for general corporate purposes.

Vericel Corporation (NASDAQ:VCEL) announced that it has entered into a term loan and revolving line of credit agreement with Silicon Valley Bank, providing access to up to $15 million of new capital to the company to be used for general corporate purposes.
According to the news:

Additional details concerning the credit facility and term loan will be contained in the company’s Current Report on Form 8-K to be filed shortly with the Securities and Exchange Commission.

Vericel’s chief financial officer and vice president of corporate development Gerard Michel:

These loan facilities provide the flexibility, at a low cost of capital, to invest in our key future growth drivers, Epicel and MACI, without diluting our current shareholders.

Click here to view the full press release. 

The Conversation (0)
×